Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Zhaoshen Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5400-9313; OpenAlex author ID A5100733350. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 2 papers · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 8

  1. A novel lncRNA PTTG3P/miR-132/212-3p/FoxM1 feedback loop facilitates tumorigenesis and metastasis of pancreatic cancer. Co-author DOI 10.1038/s41420-020-00360-5↗
  2. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells. First author DOI 10.1053/j.gastro.2014.04.048↗
  3. Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications. Last author DOI 10.1155/2014/386561↗
  4. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells. Co-author DOI 10.1097/mpa.0b013e3182962acb↗
  5. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-12-3859↗
  6. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Co-author DOI 10.1002/ijc.26422↗
  7. Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications. Co-author DOI 10.1016/j.cytogfr.2012.06.006↗
  8. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Last author DOI 10.1007/s10620-010-1285-3↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiangyu Kong · 8 shared papers, 2011–2020 · strength 0.38
  2. Yiqi Du · 5 shared papers, 2011–2014 · strength 0.19
  3. Keping Xie · 3 shared papers, 2012–2014 · strength 0.12
  4. Wenyu Liu · 1 shared paper, 2020 · strength 0.11
  5. Huiqing Zhang · 1 shared paper, 2020 · strength 0.11
  6. Huiyun Zhu · 1 shared paper, 2020 · strength 0.11
  7. Fanyang Kong · 1 shared paper, 2020 · strength 0.11
  8. Kaixuan Wang · 1 shared paper, 2020 · strength 0.11
  9. Jun Gao · 3 shared papers, 2011–2013 · strength 0.09
  10. Yan-fang Gong · 3 shared papers, 2011–2013 · strength 0.09
  11. Jiujie Cui · 2 shared papers, 2013–2014 · strength 0.07
  12. Jianqiang Liu · 2 shared papers, 2012–2013 · strength 0.07
  13. Tao Sun · 1 shared paper, 2014 · strength 0.06
  14. Dacheng Xie · 1 shared paper, 2014 · strength 0.04
  15. Daoyan Wei · 1 shared paper, 2014 · strength 0.04
  16. Weihua Jiang · 1 shared paper, 2014 · strength 0.04
  17. Lei Li · 1 shared paper, 2014 · strength 0.04
  18. Hui Chen · 1 shared paper, 2013 · strength 0.04
  19. Minghao Liu · 1 shared paper, 2013 · strength 0.04
  20. Hongyu Wu · 1 shared paper, 2013 · strength 0.04
  21. Chen Huang · 1 shared paper, 2013 · strength 0.03
  22. Liwei Wang · 1 shared paper, 2013 · strength 0.03
  23. Xiaowei Wang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.